BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
Queensland Health
Harvard Business School
Farmers Insurance
Chubb
McKinsey
Fuji
Accenture
Federal Trade Commission

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,612,109

« Back to Dashboard

Which drugs does patent 7,612,109 protect, and when does it expire?

Patent 7,612,109 protects INJECTAFER and is included in one NDA.

This patent has forty-one patent family members in twenty-eight countries.
Summary for Patent: 7,612,109
Title:Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
Abstract: Water soluble iron carbohydrate complex obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, process for its production and medicament for the treatment and prophylaxis of iron deficiency conditions.
Inventor(s): Geisser; Peter (St. Gallen, CH), Philipp; Erik (Wittenbach, CH), Richle; Walter (Gossau, CH)
Assignee: Vifor (International) AG (St. Gallen, CH)
Application Number:10/531,895
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process;

Drugs Protected by US Patent 7,612,109

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,612,109

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 49 552Oct 23, 2002
PCT Information
PCT FiledOctober 20, 2003PCT Application Number:PCT/EP03/11596
PCT Publication Date:May 06, 2004PCT Publication Number: WO2004/037865

Non-Orange Book US Patents Family Members for Patent 7,612,109

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,376,505 Aqueous iron carbohydrate complexes, their production and medicaments containing them ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,612,109

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Taiwan I265028 ➤ Subscribe
Taiwan 200420289 ➤ Subscribe
Slovenia 2287204 ➤ Subscribe
Saudi Arabia 2095 ➤ Subscribe
Slovenia 1554315 ➤ Subscribe
Russian Federation 2303039 ➤ Subscribe
Russian Federation 2005115455 ➤ Subscribe
Portugal 2287204 ➤ Subscribe
Portugal 1554315 ➤ Subscribe
Peru 05712004 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chubb
Federal Trade Commission
Mallinckrodt
Accenture
Merck
QuintilesIMS
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot